Skip to main content

Day: November 22, 2019

SIKA WINS SWISS TECHNOLOGY AWARD

SIKA WINS SWISS TECHNOLOGY AWARDSika has won the Swiss Technology Award 2019 in the “Innovation Leaders” category. It received the award for its new, high-performance adhesive technology used in lightweight construction in the field of transportation. The prize was awarded on November 21, at the Swiss Innovation Forum in Basel in the presence of 1,000 decision-makers in business, politics, science and the media.Over one hundred companies competed for Switzerland’s most important technology prize, which is awarded annually by the Swiss Innovation Forum. Sika was recognized by the jury for its innovative strength and was awarded the prize for its latest innovation: SikaForce® Powerflex, a new adhesive technology that combines the characteristics of elastic and high-strength structural adhesives in a single product. SikaForce® Powerflex...

Continue reading

SIKA GEWINNT SWISS TECHNOLOGY AWARD

SIKA GEWINNT SWISS TECHNOLOGY AWARDSika hat den Swiss Technology Award 2019 in der Kategorie „Innovation Leaders“ gewonnen. Prämiert wurde eine neue leistungsstarke Klebstofftechnologie, die bei der Leichtbauweise im Transportwesen zum Einsatz kommt. Der Preis wurde am 21. November am Swiss Innovation Forum in Basel vor mehr als 1‘000 Entscheidern aus Wirtschaft, Politik, Wissenschaft und Medien vergeben.LEICHTERE UND UMWELTFREUNDLICHERE FAHRZEUGE DANK SIKAMit SikaForce® Powerflex können beispielsweise die Hersteller von Autos, Schienenfahrzeugen, Bussen oder Lastwagen künftig neuartige, leichtere und umweltfreundlichere Fahrzeugkonzepte bei gleichzeitig hoher Karosseriefestigkeit, guter Elastizität und somit idealen mechanischen Eigenschaften realisieren. Die in der Produktion eingesetzten und mit SikaForce® Powerflex verklebten...

Continue reading

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 22 November 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares of common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in the Offer to Purchase dated March 7, 2019 (as it may be amended and supplemented from time to time, the “Offer”).Attachment22112019_MR_Spark Extension_EN

Continue reading

K. Hovnanian Enterprises, Inc. Announces Amendments To Exchange Offers And Consent Solicitations

MATAWAN, N.J., Nov. 21, 2019 (GLOBE NEWSWIRE) — Hovnanian Enterprises, Inc. (NYSE: HOV) (the “Company”) announced today that its wholly-owned subsidiary, K. Hovnanian Enterprises, Inc. (the “Issuer”), has amended certain terms of its previously announced offers to exchange (the “Exchange Offers”) its outstanding 10.000% senior secured notes due 2022 (the “Old 2022 Notes”) and outstanding 10.500% senior secured notes due 2024 (the “Old 2024 Notes” and, together with the Old 2022 Notes, the “Old Notes”) for up to $240,000,000 aggregate principal amount (the “New Notes Cap”) of 10.000% 1.75 Lien Notes due 2025 (the “New 2025 Notes”) to be issued by the Issuer and guaranteed by the Company and substantially all of its subsidiaries, other than the Issuer, its home mortgage subsidiaries, certain of its title insurance subsidiaries, joint...

Continue reading

Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock

CANTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the pricing of an underwritten public offering of 9,000,000 shares of its Class A common stock, offered at a price to the public of $5.00 per share.  The gross proceeds to Organogenesis Holdings from this offering are expected to be $45.0 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Organogenesis Holdings. Organogenesis Holdings has granted the underwriters a 30-day option to purchase up to an aggregate of 1,350,000 additional shares of its Class A common stock.  The...

Continue reading

Orocobre Limited – Results of the 2019 Annual General Meeting

BRISBANE, Australia, Nov. 21, 2019 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) wishes to announce that all resolutions were passed as ordinary resolutions following a poll at the Annual General Meeting held this morning, 22 November 2019.Details of the votes cast are as follows:Mr. Rick AnthonJoint Company SecretaryFor more information please contact:Andrew BarberInvestor Relations Manager                                                                              Orocobre Limited                                                                                                                              T: +61 7 3871 3985                                                                                            M: +61 418 783 701                                                                                                          E:...

Continue reading

Orocobre Limited – 2019 Annual General Meeting Chairman’s Address

BRISBANE, Australia, Nov. 21, 2019 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) wishes to provide the following transcript of the Chairman’s Address from the 2019 Annual General Meeting.I welcome you all to this the 14th Annual General Meeting (AGM) of Orocobre Limited. My name is Robert Hubbard and I am a Non-Executive Director and the Chairman of Orocobre and will be chairing today’s meeting.I would like to introduce the Directors and company officers in attendance today – Managing Director, Martín Pérez de Solay and Non-Executive Directors Leanne Heywood and Richard Seville. Also, with us are our joint company secretaries, Neil Kaplan, the CFO of Orocobre and Rick Anthon, the head of corporate development and group general counsel. David Hall, Andrew Barber and other members of the Orocobre...

Continue reading

O3 Mining Completes Acquisition of Option to Acquire Garrison Claims

TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — O3 Mining Inc. (TSX.V:OIII) (“O3 Mining” or the “Corporation”) is pleased to announce that it has completed the purchase of an option to acquire 10 patented mineral claims in the Garrison township (the “Option“) pursuant to an asset purchase agreement with Metals Creek Resources Corp. (“Metals Creek“) dated November 14, 2019 (“Asset Purchase Agreement“).Pursuant to the Asset Purchase Agreement, the Corporation acquired the Option in exchange for (i) C$250,000 (“Purchase Price“) which will be satisfied by the issuance of such number of common shares of the Corporation that is equal to the Purchase Price divided by the issue price of $3.88 (collectively, the “Consideration Shares“), for total shares consideration...

Continue reading

Madison Pacific Properties Inc. announces the results for the year ended August 31, 2019

VANCOUVER, British Columbia, Nov. 21, 2019 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the year ended August 31, 2019.The results reported are pursuant to International Financial Reporting Standards (IFRS) for public companies.For the year ended August 31, 2019, the Company is reporting net income of $36.2 million (2018: $44.0 million); cash flows from operating activities before changes in non-cash operating balances of $13.3 million (2018: $13.7 million); and income per share of $0.59 (2018: $0.72). Included in net income is an after-tax net gain from the fair value adjustment on investment properties of $25.4 million (2018: $32.4 million).The Company currently owns approximately $553 million in investment and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.